Table of Contents

company-logo

Elicio Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases. The company's lead product candidate is ELI-002, an AMP therapeutic vaccine for the treatment of KRAS-driven cancers. It is also developing ELI-004, an AMP-modified CpG adjuvant, a component of ELI-002; ELI-007, a lymph node targeted AMP-peptide vaccine for mutant BRAF-driven cancers; ELI-008, a multivalent lymph node targeted AMP-peptide vaccine for mutant TP53-expressing cancers; ELI-005, a vaccine candidate for the prevention of COVID-19; ELI-011 for the treatment of hematological cancers; and ELI-012, a mKRAS TCR T cell AMP-lifier designs to use in combination with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company is headquartered in Boston, Massachusetts.

Elicio Therapeutics Dividend Announcement

• Elicio Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Elicio Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Elicio Therapeutics Dividend History

Elicio Therapeutics Dividend Yield

Elicio Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Elicio Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Elicio Therapeutics Financial Ratios

P/E ratio-1.45
PEG ratio-0.01
P/B ratio-3.58
ROE4263.30%
Payout ratio0.00%
Current ratio3.40
Quick ratio3.40
Cash Ratio2.88

Elicio Therapeutics Dividend FAQ

Does Elicio Therapeutics stock pay dividends?
Elicio Therapeutics does not currently pay dividends to its shareholders.
Has Elicio Therapeutics ever paid a dividend?
No, Elicio Therapeutics has no a history of paying dividends to its shareholders. Elicio Therapeutics is not known for its dividend payments.
Why doesn't Elicio Therapeutics pay dividends?
There are several potential reasons why Elicio Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Elicio Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Elicio Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Elicio Therapeutics a dividend aristocrat?
Elicio Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Elicio Therapeutics a dividend king?
Elicio Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Elicio Therapeutics a dividend stock?
No, Elicio Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Elicio Therapeutics stocks?
To buy Elicio Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Elicio Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.